Aspiriant, LLC Jpmorgan Chase & CO Alerian Ml Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Jan 27, 2020	SELL	N/A	-13,547 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	N/A	-20,840 Reduced 60.6%	13,547 $314,000
Q2 2019 Aug 06, 2019	SELL	N/A	-30,664 Reduced 47.14%	34,387 $862,000
Q1 2019 May 03, 2019	SELL	N/A	-30,914 Reduced 32.21%	65,051 $1.66 Million
Q4 2018 Feb 04, 2019	BUY	N/A	72,670 Added 311.96%	95,965 $2.14 Million
Q3 2018 Oct 26, 2018	SELL	N/A	-3,927 Reduced 14.43%	23,295 $640,000
Q2 2018 Aug 07, 2018	SELL	N/A	-1,025 Reduced 3.63%	27,222 $724,000
Q1 2018 May 04, 2018	BUY	N/A	14,101 Added 99.68%	28,247 $678,000
Q4 2017 Jan 31, 2018	SELL	N/A	-55,554 Reduced 79.7%	14,146 $389,000
Q3 2017 Nov 13, 2017	BUY	N/A	69,700	69,700 $1.97 Million

Others Institutions Holding AMJ

# of Institutions

15

Shares Held

662K

Call Options Held

200

Put Options Held

0

About JPMORGAN CHASE & CO ALERIAN ML

Ticker AMJ
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.